GenMark Diagnostics to Present at Two Upcoming Investor Conferences
February 17 2015 - 4:42PM
Business Wire
- Raymond James’ 36th Annual
Institutional Investors Conference on March 2, 2015
- Cowen and Company’s 35th Annual
Health Care Conference on March 4, 2015
GenMark Diagnostics, Inc. (NASDAQ: GNMK), a leading provider of
automated, multiplex molecular diagnostic testing systems,
announced today that Hany Massarany, President and Chief Executive
Officer, will present at the Raymond James 36th Annual
Institutional Investors Conference to be held at the JW Marriott
Grande Lakes in Orlando, Florida on Monday, March 2, 2015 at 2:50
pm Eastern Time. Mr. Massarany will also present at the Cowen and
Company 35th Annual Health Care Conference to be held at the Boston
Marriott Copley Place in Boston, Massachusetts on Wednesday, March
4, 2015, at 9:20 am Eastern Time.
The presentation will be made available at http://ir.genmarkdx.com.
ABOUT GENMARK DIAGNOSTICS
GenMark Diagnostics (NASDAQ: GNMK) is a leading provider of
automated, multiplex molecular diagnostic testing systems that
detect and measure DNA and RNA targets to diagnose disease and
optimize patient treatment. Utilizing GenMark’s proprietary
eSensor® detection technology, GenMark’s eSensor XT-8TM system is
designed to support a broad range of molecular diagnostic tests
with a compact, easy-to-use workstation and self-contained,
disposable test cartridges. The eSensor detection technology is
also incorporated into GenMark’s sample-to-answer system, ePlexTM.
For more information, visit www.genmarkdx.com.
GenMark Diagnostics, Inc.Hany MassaranyPresident, Chief
Executive Officer760-448-4358
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Mar 2024 to Apr 2024
GenMark Diagnostics (NASDAQ:GNMK)
Historical Stock Chart
From Apr 2023 to Apr 2024